• Find people
• Intranet

News / General information

• 15/04/2010 - General information

  A work published in Genome Research identifies many new functional amino acid tandem repeats in human proteins

  

  The Evolutionary Genomics group of GRIB (IMIM- UPF), led by Mar Albà, has published at the journal Genome Research a study that shows, using a comparative genomics approach, that many more amino acid tandem repeats in human proteins than previously suspected are likely to be functional.

  Més informació "A work published in Genome Research identifies many new functional amino acid tandem repeats in human proteins"

• 01/03/2010 - General information

  iPHACE, Software to Visually Explore Pharmacological Space

  

  On 15 February, the international journal Bioinformatics, one of the best in the field of mathematics and computational biology, published an article on a web application developed by the Laboratorio de Quimiogenómica, directed by Jordi Mestres, which is part of the IMIM-UPF Biomedicine IT Research Group (GRIB).

  Més informació "iPHACE, Software to Visually Explore Pharmacological Space"

• 25/02/2010 - General information

  José Antonio Pascual re-elected as President of the IPC Anti-doping Committee

  

  José Antonio Pascual, member of the Bioanalysis and Analytical Services Research Group of the Neuropsychopharmacology Programme and deputy director of the Anti-doping Control Laboratory, has been re-elected President of the International Paralympic Committee’s Anti-doping Committee for the next 4 years.

  Més informació "José Antonio Pascual re-elected as President of the IPC Anti-doping Committee"

• 23/02/2010 - General information

  25 European organisations unite their efforts towards a better prediction of toxic effects of new drug candidates

  

  The Innovative Medicines Initiative (IMI) funds for 5 years a consortium consisting of 13 European pharmaceutical companies and 12 academic groups and SMEs to develop information technologies-based solutions for improved toxicity prediction of new drug candidates. The academic coordination of the project is in charge of Ferran Sanz, Director of GRIB (IMIM-UPF).

  Més informació "25 European organisations unite their efforts towards a better prediction of toxic effects of new drug candidates"

• 28/01/2010 - General information

  IntOgen, an interface designed as an essential tool for cancer research

  

  IntOgen, an interface designed as an essential tool for cancer research The Biomedical Genomics laboratory of the IMIM and UPF’s Biomedical Informatics Research Group (GRIB in Spanish), led by Núria Lopez-Bigas, has developed an innovative system for analysing and integrating large amounts of cancer genomic data.The results produced by this multidimensional resource, known as IntOGen, can be viewed on the web interface www.intogen.org.

  Més informació "IntOgen, an interface designed as an essential tool for cancer research"

• 25/01/2010 - General information

  An IMIM study makes the American Heart Association’s top 10 list

  

  Every year since 1996, the American Heart Association lists the top 10 most important scientific advances related to cardiovascular diseases and stroke. This year, the top 10 includes a study involving researchers from the Cardiovascular Epidemiology and Genetics Research Group from IMIM-Hospital del Mar. It was published last June in the prestigious journal Nature Genetics.

  Més informació "An IMIM study makes the American Heart Association’s top 10 list"

• 03/12/2009 - General information

  Eating Disorders are a Public Health Problem that Affect Young Women to a Greater Extent

  

  As part of the European Study of the Epidemiology of Mental Disorders (ESEMeD) and the World Mental Health Survey Initiative (WMH project), researchers from the Municipal Institute for Medical Research (IMIM-Hospital del Mar) have participated in a study to establish the prevalence of the major eating disorders: anorexia, bulimia and binge eating disorder.

  Més informació "Eating Disorders are a Public Health Problem that Affect Young Women to a Greater Extent"

• 30/11/2009 - General information

  Unemployment, low level of education and living as a couple worsen the perception of social discrimination among individuals with mental disorders

  

  For the first time, researchers from the Municipal Institute of Medical Research (IMIM-Hospital del Mar) have studied, within the international study setting of ESEMeD, how individuals with mental disorders perceive social rejection and how this affects their well-being and the progress of their illness. Individuals with a mental disorder who feel stigmatised have a lower quality of life and more social and work-related limitations than those with a mental disorder who do not feel stigmatised.

  Més informació "Unemployment, low level of education and living as a couple worsen the perception of social discrimination among individuals with mental disorders"

• 07/07/2009 - General information

  The AECC grants €1,200,000 to a project in which IMIM is participating

  Following the assessment by the National Agency of Evaluation and Prospective Studies (ANEP), the Foundation Board of the Spanish Association Against Cancer (AECC) approved, on 17 June, the awarding of two grants worth 1,200,000 euros over a period of 5 years to research programmes that jointly coordinate and run a translational research programme.

  Més informació "The AECC grants €1,200,000 to a project in which IMIM is participating"

• 15/06/2009 - General information

  Jordi Mestres, editor of Molecular Informatics

  Jordi Mestres, coordinator of the Chemogenomics Laboratory at IMIM-Hospital del Mar, will be one of the 4 editors of the new magazine Molecular Informatics that will be published by Wiley-VCH publishers starting in January 2010.

  Més informació "Jordi Mestres, editor of Molecular Informatics"